201 filings
Page 3 of 11
424B5
omo7cql tvo1rc8
1 Dec 22
Prospectus supplement for primary offering
4:05pm
EFFECT
sb7uxd
30 Nov 22
Notice of effectiveness
12:15am
CORRESP
wg24k7z1
23 Nov 22
Correspondence with SEC
12:00am
UPLOAD
ugx6it8ntj
22 Nov 22
Letter from SEC
12:00am
8-K
sor6kzv mgxe
10 Nov 22
UroGen Pharma Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
8:10am
8-K
zoznyjyzib3e 1e2c2
9 Nov 22
Departure of Directors or Certain Officers
6:13am
8-K
8xxvn0n
21 Oct 22
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:05pm
8-K
zsylsve5
12 Sep 22
Departure of Directors or Certain Officers
8:27am
S-8
hslh73pf o58q38qfzw
11 Aug 22
Registration of securities for employees
8:12am
8-K
f958 ap85njl
11 Aug 22
UroGen Pharma Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
8:11am
8-K
cvskrbnj5rbj71uzk1
13 Jun 22
Departure of Directors or Certain Officers
4:55pm
DEFA14A
inx2r2ngj41xk014nm3
17 May 22
Additional proxy soliciting materials
4:06pm
8-K
zqbzufttpgngeg
10 May 22
UroGen Pharma Reports First Quarter 2022 Financial Results
9:11am
DEFA14A
nbk2y 7usn2cq2ei1umf
2 May 22
Additional proxy soliciting materials
4:56pm